These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169 [Abstract] [Full Text] [Related]
6. [Primary central nervous system lymphoma--a report of 32 cases with literature review]. Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ. Ai Zheng; 2006 Apr 01; 25(4):476-80. PubMed ID: 16613684 [Abstract] [Full Text] [Related]
8. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil]. Qin Y, Shi YK, He XH, Yang JL, Yang S, Yu YX, Li B, Wang QL, Zhou LQ, Sun Y. Ai Zheng; 2006 Apr 01; 25(4):481-5. PubMed ID: 16613685 [Abstract] [Full Text] [Related]
13. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ. Ai Zheng; 2006 Dec 01; 25(12):1538-42. PubMed ID: 17166382 [Abstract] [Full Text] [Related]
15. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis. Kiewe P, Fischer L, Martus P, Thiel E, Korfel A. Cancer; 2008 Apr 15; 112(8):1812-20. PubMed ID: 18318432 [Abstract] [Full Text] [Related]
16. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Escalón MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH. Cancer; 2005 May 15; 103(10):2091-8. PubMed ID: 15816054 [Abstract] [Full Text] [Related]
17. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M, European Organization for Research and Treatment of Cancer Lymphoma Group. J Clin Oncol; 2003 Dec 15; 21(24):4483-8. PubMed ID: 14597741 [Abstract] [Full Text] [Related]
18. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF. Zhonghua Zhong Liu Za Zhi; 2006 Jan 15; 28(1):58-61. PubMed ID: 16737624 [Abstract] [Full Text] [Related]